MedPath

Effect of Functional Electrical Stimulation and Motor Relearning Programme approach on Gait in Stroke individuals

Not yet recruiting
Conditions
Spastic hemiplegia,
Registration Number
CTRI/2022/02/040191
Lead Sponsor
Not Applicable
Brief Summary

Aim- Aim of the study is to measure effect of Functional Electrical Stimulation along with Motor Relearning Programme approach on Gait speed and Cadence in sufferers with Sub-acute Stroke.

Design- Randomized Control Trial

Participants- In this study, 30 sub-acute stroke individuals will be taken out of which 15 individuals will be assigned randomly to Experimental Group and 15 individuals to Conventional Group.

Intervention- In Experimental Group  both FES and MRP will be given and in Conventional Group only MRP will be given.

Outcome measures- Primary outcome of this study will be gait speed and cadence. Secondary outcome will be Ambulation and Gait.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Individuals with 3 weeks to six months after stroke onset Age 45-60 years Individuals with MCA stroke Individuals with and without usage of assistive device Individuals who are able to walk 10-meter distance Individuals with foot drop Male and female individuals will be included Stable medical conditions.

Exclusion Criteria

Individuals with severe cardiopulmonary and respiratory conditions Severe sensory disturbance Individuals with ataxia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gait speed and Cadence3 weeks
Secondary Outcome Measures
NameTimeMethod
Functional Ambulation Classification (FAC) and Tinetti Gait Scale3 weeks

Trial Locations

Locations (1)

Vimhans Nayati Super Specialty Hospital

🇮🇳

South, DELHI, India

Vimhans Nayati Super Specialty Hospital
🇮🇳South, DELHI, India
Dr Prateek Gaur PT
Principal investigator
9891304886
prateek.physiotherapist@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.